Using oral vancomycin prescriptions as a proxy measure for Clostridium difficile infections: A spatial and time series analysis

Infection Control and Hospital Epidemiology

Volumn 32, Issue 7, 2011, Pages 723-726

  Polgreen, Philip M ^a,b   Yang, Ming ^b   Kuntz, Jennifer L ^c   Laxminarayan, Ramanan ^d,e,f   Cavanaugh, Joseph E ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d Center for Disease Dynamics Economics and Policy   (United States)

^e PRINCETON UNIVERSITY   (United States)

^f PUBLIC HEALTH FOUNDATION OF INDIA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CUSTODY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG MARKETING; HUMAN; PRESCRIPTION; SPATIAL AUTOCORRELATION ANALYSIS; TIME SERIES ANALYSIS;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CLUSTER ANALYSIS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; HUMANS; LINEAR MODELS; OHIO; POPULATION SURVEILLANCE; SEASONS; VANCOMYCIN;

EID: 79958749951     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/660858     Document Type: Article

References (9)

1. Proctor ME, Blair KA, Davis JP. Surveillance data for waterborne illness detection: an assessment following a massive waterborne outbreak of Cryptosporidium infection. Epidemiol Infect 1998;120: 43-54.
2. Das D, Metzger K, Heffernan R, Balter S, Weiss D, Mostashari F. Monitoring over-the-counter medication sales for early detection of disease outbreaks-New York City. MMWR Morb Mortal Wkly Rep 2005;54(suppl):41-46.
3. Vergu E, Grais RF, Sarter H, et al. Medication sales and syndromic surveillance, France. Emerg Infect Dis 2006;12:416-421.
4. Edge VL, Pollari F, Lim G, et al. Syndromic surveillance of gastrointestinal illness using pharmacy over-the-counter sales: a retrospective study of waterborne outbreaks in Saskatchewan and Ontario. Can J Public Health 2004;95:446-450.
5. Ohio Department of Health. Final report for rates of Clostridium difficile for Ohio hospitals and nursing homes January 1-December 31, 2006. Columbus, OH: Ohio Department of Health. http://www.odh.ohio.gov/alerts/cdiff1.aspx. Accessed February 1, 2008.
6. Campbell RJ, Giljahn L, Machesky K, et al. Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol 2009;30:526-533.
7. Agency for Healthcare Research and Quality. Nationwide in patient sample (NIS) healthcare cost and utilization project. Washington, DC: Agency for Healthcare Research and Quality. http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed February 19, 2010.
8. Dubberke ER, Reske KA, McDonald LC, Fraser VJ. ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis 2006;12:1576-1579.
9. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45:302-307.